Showing results (311-320 of 1,393) with videos related to

Sort By:
Pageof 140
JCO Precision Oncology|April 10, 2025
Whatever It Takes: Parents' Perspectives of Patient-Derived Xenograft Mouse Models for Poor Prognosis Childhood CancerEden G Robertson, Kate Hetherington, Jacqueline D Hunter, et al.
JCO Precision Oncology|April 10, 2025
Serial Circulating Tumor DNA Sequencing to Monitor Response and Define Acquired Resistance to Letrozole/Abemaciclib in Endometrial CancerPanagiotis A Konstantinopoulos, Mingyang Cai, Elizabeth K Lee, et al.
JCO Precision Oncology|March 26, 2025
Utility of Whole-Body Magnetic Resonance Imaging Surveillance in Children and Adults With Cancer Predisposition Syndromes: A Retrospective StudyFrances Victoria Fajardo Que, Nur Diana Binte Ishak, Shao-Tzu Li, et al.
JCO Precision Oncology|March 26, 2025
Expanding the Therapeutic Reach of Chimeric Antigen Receptor T-Cells and Bispecific T-Cell Engagers Across Solid TumorsWilliam K Gerber, Yiyu Xie, Shyam A Patel
JCO Precision Oncology|June 27, 2024
Clinical Utility of Tumor Next-Generation Sequencing Panel Testing to Inform Treatment Decisions for Patients With Advanced Solid Tumors in a Tertiary Care CenterLucia Bogdan, Ramy R Saleh, Lisa Avery, et al.
JCO Precision Oncology|June 27, 2024
Real-World Impact of an In-House Dihydropyrimidine Dehydrogenase (DPYD) Genotype Test on Fluoropyrimidine Dosing, Toxicities, and Hospitalizations at a Multisite Cancer CenterD Grace Nguyen, Sarah A Morris, Alicia Hamilton, et al.
JCO Precision Oncology|June 12, 2024
Urine Biopsy as Dynamic Biomarker to Enhance Clinical Staging of Bladder Cancer in Radical Cystectomy CandidatesUttam Satyal, Henkel Valentine, David Liu, et al.
JCO Precision Oncology|June 21, 2024
Exceptional Response to Trastuzumab Deruxtecan in a Patient With Recurrent Ovarian Clear Cell Carcinoma With Human Epidermal Growth Factor Receptor 2 ExpressionBen L Kong, Jayne M Stommel, Jamie M Keck, et al.
JCO Precision Oncology|June 17, 2024
Chemotherapy-Induced Peripheral Neuropathy and Falls in Cancer Survivors Relate to Digital Balance and Gait ImpairmentsVrutangkumar V Shah, Daniel Muzyka, Carolyn Guidarelli, et al.
JCO Precision Oncology|May 23, 2024
Dabrafenib for Pilocytic Astrocytoma With BRAF V599insRyuma Tanaka, Kelly Mrachek, Elsa Arocho-Quinones, et al.
Pageof 140